Skip to main content

. 1970 Oct 10;4(5727):93–94. doi: 10.1136/bmj.4.5727.93

L-dopa treatment failure: explanation and correction.

L Rivera-Calimlim, C A Dujovne, J P Morgan, L Lasagna, J R Bianchine

PMCID: PMC1819624 PMID: 5482325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bartholini G., Pletscher A. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase. J Pharmacol Exp Ther. 1968 May;161(1):14–20. [PubMed] [Google Scholar]
Calne D. B., Stern G. M., Laurence D. R., Sharkey J., Armitage P. L-dopa in postencephalitic parkinsonism. Lancet. 1969 Apr 12;1(7598):744–746. doi: 10.1016/s0140-6736(69)91751-6. [DOI] [PubMed] [Google Scholar]
Cotzias G. C., Papavasiliou P. S., Gellene R. Modification of Parkinsonism--chronic treatment with L-dopa. N Engl J Med. 1969 Feb 13;280(7):337–345. doi: 10.1056/NEJM196902132800701. [DOI] [PubMed] [Google Scholar]
Mawdsley C. Treatment of Parkinsonism with Laevo-dopa. Br Med J. 1970 Feb 7;1(5692):331–337. doi: 10.1136/bmj.1.5692.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
Peaston M. J., Bianchine J. R. Metabolic studies and clinical observations during L-dopa treatment of Parkinson's disease. Br Med J. 1970 Feb 14;1(5693):400–403. doi: 10.1136/bmj.1.5693.400. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES